Literature DB >> 15638994

Transport of prostaglandin E1 across the blood-brain barrier in rats.

T Taogoshi1, A Nomura, T Murakami, J Nagai, M Takano.   

Abstract

The transport of prostaglandin E(1) (PGE(1)) across the blood-brain barrier (BBB) was characterized using an in-situ rat brain perfusion technique. The uptake of [(3)H]PGE(1) was not affected by shortchain monocarboxylic acids (butyric acid and valeric acid). On the other hand, uptake of [(3)H]PGE(1) was significantly inhibited by medium-chain monocarboxylic acids such as hexanoic acid, enanthic acid and octanoic acid. These medium-chain monocarboxylic acids showed a more potent inhibitory effect on [(3)H]PGE(1) uptake with increasing number of carbon atoms. In contrast, there was no decrease in [(3)H]PGE(1) transport by any dicarboxylic acids with 5-8 carbon atoms. Valproic acid decreased [(3)H]PGE(1) uptake, whereas p-aminohippuric acid, a substrate for the organic anion transporter family, did not inhibit [(3)H]PGE(1) transport. Bromocresol green, an inhibitor of prostaglandin transporter (PGT), strongly decreased [(3)H]PGE(1) transport across the BBB. In addition, digoxin and taurocholate, substrates for organic anion transporting polypeptide subtype 2 (Oatp2), significantly inhibited [(3)H]PGE(1) uptake. RT-PCR analysis revealed that PGT mRNA and Oatp2 mRNA are expressed in a capillary-rich fraction from rat brain. Thus, it is suggested that PGE(1) transport across the BBB is mediated by some specific transport systems, possibly by the members of the Oatp family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638994     DOI: 10.1211/0022357055173

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  12 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier.

Authors:  Patrick T Ronaldson; Jessica D Finch; Kristin M Demarco; Colleen E Quigley; Thomas P Davis
Journal:  J Pharmacol Exp Ther       Date:  2010-12-02       Impact factor: 4.030

Review 4.  Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Brain Res       Date:  2015-03-18       Impact factor: 3.252

5.  The effect of prostaglandin E1 on brainstem blood flow disturbance in an animal model of vertebrobasilar insufficiency.

Authors:  Toshiaki Yamanaka; Takayuki Murai; Yachiyo Sawai; Hideyuki Okamoto; Hiroshi Hosoi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

Review 6.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

7.  Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations.

Authors:  Tushar K Vyas; Aliasgar Shahiwala; Mansoor M Amiji
Journal:  Int J Pharm       Date:  2007-06-19       Impact factor: 5.875

8.  Low-dose but not high-dose prostaglandin E(1) improves the histological outcome of severe forebrain ischemia in rats.

Authors:  Yoshihide Miura; Kaoru Kanazawa; Noriko Yokoo; Kazue Iizawa; Masayuki Okada; Shinya Oda; Masaki Nakane
Journal:  J Anesth       Date:  2010-02-18       Impact factor: 2.078

9.  Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole.

Authors:  Shin-Ichi Akanuma; Yasuo Uchida; Sumio Ohtsuki; Masanori Tachikawa; Tetsuya Terasaki; Ken-Ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2011-10-21

10.  Acute macular edema following intracorporeal prostaglandin injection for erectile dysfunction.

Authors:  Masumi G Asahi; Calvin Chou; Ron P Gallemore
Journal:  Int Med Case Rep J       Date:  2015-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.